Nuburu SEC Filings

Nuburu, Inc. (BURUW) filed a Form 424B4 prospectus describing an offering of Pre-Funded Warrants and Common Warrants and disclosing material corporate and financing developments. The document sets placement agent fees at up to 7.5% on gross proceeds up to $10,000,000 and an additional 6.0% on amounts above $10,000,000. It warns investors of immediate dilution, potential cashless warrant exercises that amplify dilution, and that the company will likely need additional capital even if the offering is successful. The filing discloses numerous unsecured convertible notes issued in 2025 with conversion prices tied to discounted VWAPs, an Agile Note bearing 44% interest with weekly repayments through November 2025, and multiple financings and exchanges with Indigo Capital, Brick Lane, Bomore, Torcross and others. The company has received an NYSE American notice of noncompliance regarding delisting proceedings for its Public Warrants, recorded material weaknesses and restatements tied to debt accounting, and large potential share issuances from conversions/options/notes that could substantially dilute shareholders. The prospectus also highlights product advantages of its blue laser technology and strategic focus on defense licensing.

NUBURU, INC. filed a new S-1 under Rule 462(b) to register additional securities for its ongoing reasonable best efforts public offering. This filing increases the maximum aggregate offering price by $3,605,041, consisting of common warrants to purchase up to $3,605,041 worth of the company’s common stock. The additional securities are of the same classes as those in the prior S-1 (File No. 333-290147) and represent no more than 20% of the maximum aggregate offering price previously set forth. The company also certifies that it will wire the related SEC filing fee and has sufficient funds to cover it.

Nuburu, Inc. (BURU) filed an S-1 describing its business, corporate history and material risks ahead of an offering. The filing discloses a completed business combination that converted Legacy Nuburu securities into Nuburu equity and significant financings through convertible notes, warrants and preferred stock that may result in substantial dilution (examples include 38,276,895 shares issuable upon conversion of convertible notes and 1,632,187 shares issuable upon exercise of outstanding warrants as of Sept 2, 2025). The company received a Notice of Noncompliance from NYSE American and has restated prior financials while identifying material weaknesses in internal controls. The prospectus lists many risk factors including financing needs, lack of commercialization, potential delisting, exposure to litigation and intellectual property risks, and numerous unsecured convertible financings with varying conversion discounts and maturities through mid-2026.

Nuburu, Inc. entered into a financing agreement by issuing a $125,000 unsecured, convertible note to Brick Lane Capital Management Limited in a private placement. The note carries no interest while it is not in default, matures on September 2, 2026, and can be converted into common stock at a price equal to 70% of the lowest volume-weighted average price during the five days before conversion.

Stock issuances on conversion are capped at 19.9% of Nuburu’s outstanding common stock as of the agreement date until stockholders approve the transaction, and Brick Lane may not own more than 9.9% of the company’s outstanding common stock at any time. The note is subordinated to the Series A Preferred Stock for dividends and liquidation rights and includes customary representations, covenants, and events of default. The securities were sold under a registration exemption for private placements to an accredited investor.

Nuburu, Inc. signed a binding commitment letter revising its plan to acquire a 70% stake in Italian vehicle maker Tekne S.p.A., valuing Tekne at $60 million and the 70% interest at about $42 million. The deal, adjusted in response to Italy’s Golden Power review, will occur in two stages: a 3% stake expected in September 2025 and the remaining 67% by the end of 2025, subject to definitive agreements and regulatory approvals.

To support Tekne’s working capital, Nuburu agreed to help arrange up to EUR 40 million of financing over 12 months, including EUR 10.5 million of cash capital support and a EUR 30 million inventory monetization program using the Supply@ME platform. Nuburu and Tekne will also form a U.S. joint venture, 80% owned by Nuburu, expected to generate up to $7.5 million of revenue while the review is completed. Completing the second stage is anticipated to require issuing more than 19.99% of Nuburu’s outstanding stock, which will require stockholder approval via a proxy process.

Nuburu, Inc. (BURU) filing is a lengthy S-1/prospectus describing its post-business-combination structure, capital instruments, financing arrangements, and extensive risk factors. The company completed a business combination that converted Legacy Nuburu equity and warrants into Nuburu common and preferred stock and adopted new governing documents. The filing discloses multiple convertible notes, warrants, a Standby Equity Purchase Agreement (SEPA) with up to $100 million potential funding (30 million shares registered now), and numerous related-party and investor financings with varying conversion discounts and maturities through 2026. It records material weaknesses in internal control, a Notice of Noncompliance from NYSE American, restatements/misclassifications in debt and financing costs, asset write-downs tied to a leased facility, and significant potential dilution from convertible instruments, preferred stock and warrants. The prospectus lists many operational, regulatory, financing, integration, intellectual property, and market risks that could materially affect future results.

Nuburu, Inc. files an S-1 describing its Business Combination with Legacy Nuburu and material financing activity in 2025. The company issued multiple unsecured convertible notes to investors including Indigo Capital, Brick Lane, Bomore, Torcross, Diagonal and Boot with face amounts such as $1,578,495, $1,421,053, $2,108,523, $225,000 and others, many issued for capital infusions or to extinguish prior debt. Convertible instruments could convert into tens of millions of shares (38,276,895 shares assumptive conversion as of Aug 20, 2025), creating substantial dilution. The filing discloses a Notice of Noncompliance from NYSE American, prior restatements and identified material weaknesses in internal controls, and significant asset write-downs (inventory and property at leased premises written to zero in Q1 2025). The prospectus highlights extensive risk factors related to financing, commercialization, acquisitions, regulatory and operational risks and governance provisions that limit stockholder actions.

Nuburu, Inc. entered into a financing deal by issuing a $225,000 unsecured, convertible note to Indigo Capital LP in exchange for a matching capital infusion. The Indigo Note bears no interest while it is not in default, has a maturity date of August 17, 2026, and can convert into common stock at a price equal to 80% of the lowest VWAP during the five trading days before each conversion.

Common stock issued upon conversion is capped at 19.9% of the outstanding shares as of the deal date until stockholders approve the transaction, and Indigo cannot own more than 9.9% of Nuburu’s outstanding common stock at any time. The note is subordinated to Nuburu’s outstanding Series A Preferred Stock for dividend and liquidation rights. The securities were sold in a private placement to an accredited investor under a Section 4(a)(2) exemption.

Nuburu, Inc. reported substantial non-cash impairments and financing activity in the quarter. Management wrote inventory to a net realizable value of $0, fully impaired property and equipment at a leased location, and fully impaired the related operating lease right-of-use asset, recording those losses in the condensed consolidated statement of operations for the six months ended June 30, 2025. The company recorded certain financial instruments at fair value using Level 3 inputs and determined its Public Warrants had no value as of June 30, 2025. The NYSE American notified the company that it was not in compliance with continued listing standards, although trading remains ongoing under the symbol BURU with a noncompliance designation. The company completed multiple convertible note financings and other capital infusions (including Indigo Capital, Brick Lane, Bomore, Diagonal, Boot and others) with varying terms, conversion prices tied to VWAP metrics, and several high-cost notes (for example, an Agile Note bearing 44% interest). The company entered a SEPA commitment providing access to up to $100 million of Common Stock sales and issued 1,332,623 commitment-fee shares during Q2 2025. Significant preferred stock remeasurement increased a mandatorily redeemable liability to $23,889,050, generating a $10,398,050 adjustment to net loss available to common shareholders for the six months ended June 30, 2025.